GIGYF2 and cardiovascular disorder: Notably, GIGYF2 is hyper-expressed in senescent human endothelial cells and aged mouse aortas, while endothelial-specific GIGYF2 knockout provides protection against age-associated vascular dysfunction, highlighting its potential as a therapeutic target for vascular aging and age-related cardiovascular diseases.